This article reviews the role of prostaglandins (PG) in maintaining renal function in the face of vasoconstrictive substances and decreased renal blood flow. Inhibition of the synthesis of renal PG by nonsteroidal antiinflammatory drugs (NSAID) may lead to the development of hemodynamically induced renal dysfunction in patients with a decreased effective plasma volume or chronic renal insufficiency. The importance of stimulation of renal PG activity to the action of diuretics and a pharmacodynamic mechanism for NSAID-induced diuretic resistance are presented. Evidence for the relative selectivity of sulindac in inhibiting systemic PG without inhibiting renal PG is also reviewed.
Inhibition of renal PG synthesis has been postulated to be a contributing factor for other forms of NSAID-induced renal dysfunction (interstitial nephritis, analgesic-associated nephropathy). The relationship between renal PG inhibition by NSAID and these syndromes is briefly discussed.
Considering the frequent use of NSAID, it is important that practitioners are aware of the mechanisms whereby patients may develop NSAID-induced renal dysfunction and that they are able to identify patients at risk.
The top 200 prescription drugs of 1985. Am Drug1986; 193: 18–30.
2.
FlowerRJMoncadaSVaneJR. Analgesic-antipyretic and anti-inflammatory agents; drugs employed in the treatment of gout. In: GilmanAGGoodmanLSRallTWMuradF, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 7th ed.New York: Macmillan1985: 674–716.
3.
DunnMJ. Nonsteroidal antiinflammatory drugs and renal function. Annu Rev Med1984; 35: 411–28.
4.
GarellaSMatareseRA. Renal effects of prostaglandins and clinical adverse effects of nonsteroidal anti-inflammatory agents. Medicine1984; 63: 165–81.
5.
CliveDMStoffJS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med1984; 310: 563–72.
6.
StillmanMTNapierJBlackshearJL. Adverse effects of nonsteroidal antiinflammatory drugs on the kidney. Med Clin North Am1984; 68: 371–85.
7.
CarmichaelJShankelSW. Effects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function. Am J Med1985; 78: 992–1000.
8.
DunnMJZambraskiEJ. Renal effects of drugs that inhibit prostaglandin synthesis. Kidney Int1980; 18: 609–22.
9.
StokesJB. Effect of prostaglandin E2 on chloride transport across the rabbit thick ascending limb of henle. J Clin Invest1979; 64: 495–502.
10.
KokkoJP. Effect of prostaglandins on renal epithelial electrolyte transport. Kidney Int1981; 19: 791–6.
11.
RaymondKHLifschitzMD. Effect of prostaglandins on renal salt and water excretion. Am J Med1986; 80 (suppl 1A): 22–32.
12.
AndersonRJBerlTMcDonaldKMSchrierRWMcCoolAGilbertL. Evidence for an in vivo antagonism between vasopressin and prostaglandin in the mammalian kidney. J Clin Invest1975; 56: 420–6.
13.
GerberJGOlsonRDNiesAS. Interrelationship between prostaglandins and renin release. Kidney Int1981; 19: 816–21.
14.
RileyLJVlassesPRotmenschHH. Sulindac and ibuprofen inhibit furosemide-stimulated renin release but not natriuresis in men on a normal sodium diet. Nephron1985; 41: 283–8.
15.
BlackshearJLDavidmanMStillmanMT. Identification of risks for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med1983; 143: 1130–4.
16.
McCarthyJTTorresVERomeroJCWochosDNVelosaJA. Acute intrinsic renal failure. Mayo Clin Proc1982; 57: 289–96.
17.
GallerMFolkertVMSchlondorffD. Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy. JAMA1981; 246: 154–5.
18.
PatakRVMookerjeeBKBentzelCJHysertPEBabejMLeeJB. Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins1975; 10: 649–59.
19.
AttallahAA. Interaction of prostaglandins with diuretics. Prostaglandins1979; 18: 369–75.
20.
MirouzeDZipserRDReynoldsTB. Effects of inhibitors of prostaglandin synthesis on induced diuresis in cirrhosis. Hepatology1983: 50–5.
21.
RyanJRChremosANVargasRJohnsonCLMcMahonFG. The influence of nonsteroidal anti-inflammatory drugs (NSAID), [sulindac and naproxen] on natriuretic, diuretic and renin response to furosemide (abstract). Clin Pharmacol Ther1984; 35: 271.
22.
OliwEKoverGLarssonCAnggardE. Reduction by indomethacin of furosemide effects in the rabbit. Eur J Pharmacol1976; 38: 95–100.
23.
WilliamsonHEBourlandWAMarchandGR. Inhibition of furosemide-induced increase in renal blood flow by indomethacin. Proc Soc Exp Biol Med1975; 148: 164–7.
24.
RobertsDGGerberJGBarnesJSZerbeGONiesAS. Sulindac is not renal sparing in man. Clin Pharmacol Ther1985; 38: 258–65.
25.
DaskalopoulosGKronborgIKatkovWGonzalezMLaffiGZipserRD. Sulindac and indomethacin suppress the diuretic action of furosemide in patients with cirrhosis and ascites: evidence that sulindac affects renal prostaglandins. Am J Kidney Dis1985; 6: 217–21.
26.
BraterDCAndersonSBairdBCambellWB. Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men. Kidney Int1985; 27: 66–73.
27.
ElliottHC. Reduced adrenocortical steroid excretion rates in man following aspirin administration. Metabolism1962; 11: 1015–8.
28.
WebsterJ. Interactions of NSAIDs with diuretics and beta-blockers: mechanisms and clinical implications. Drugs1985; 30: 32–41.
29.
LaiwahAC YeungMactierRA. Antagonistic effect of nonsteroidal antiinflammatory drugs on furosemide-induced diuresis in cardiac failue. Br Med J1981; 283: 714.
30.
ChennavasinPSeiwellRBraterDC. Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man. J Pharmacol Exp Ther1980; 215: 77–81.
31.
KoopmansPPKatemanWGPMTanYVan GinnekanCAMGribnauFWJ. Effects of indomethacin and sulindac on hydrochlorothiazide kinetics. Clin Pharmacol Ther1985; 37: 625–8.
32.
DuraoVPrataMMConcalvesLMP. Modification of antihypertensive effects of beta-adrenoceptor blocking agents by inhibition of endogenous prostaglandin synthesis. Lancet1977; 2: 1005–7.
33.
WatkinsJAbbottECHensbyCNWebsterJDolleryCT. Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. Br Med J1980; 281: 702–5.
34.
YlitaloPPitkajarviTPyykonenMLNurmiAKSeppalaEVapaataloH. Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol. Clin Pharmacol Ther1985; 38: 443–9.
35.
BraterDC. Drug-drug and drug disease interactions with nonsteroidal anti-inflammatory drugs. Am J Med1986; 80 (suppl 1A): 62–75.
CiabattoniGCinottiGAPierucciA. Effects of sulindac and ibuprofen in patients with chronic glomerular disease: evidence for dependence of renal function on prostacyclin. N Engl J Med1984; 310: 279–83.
38.
SedorJRWilliamsSLChremosANJohnsonCLDunnMJ. Effects of sulindac and indomethacin on renal prostaglandin synthesis. Clin Pharmacol Ther1984; 36: 85–91.
LaffiGDaskalopoulosGKronborgIHsuehWGentilliPZipserRD. Effect of sulindac and ibuprofen in patients with cirrhosis and ascites. Gastroenterology1986; 90: 182–7.
41.
QuinteroEGinesPRimolaA. Sulindac reduces urinary excretion of prostaglandins and impairs renal function in cirrhosis with ascites. Nephron1986; 42: 298–303.
42.
GuarnerFGuarnerCPrietoJ. Increased synthesis of systemic prostacyclin in cirrhotic patients. Gastroenterology1986; 90: 687–94.
43.
CiabattoniGBossAHPatrignaniP. Effect of sulindac on renal and extrarenal eicosanoid synthesis. Clin Pharmacol Ther1987; 41: 380–3.
44.
PatronoCCiabattoniGRemuzziG. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. J Clin Invest1985; 76: 1011–8.
45.
FinkelsteinAFraleyDSStachuraIFeldmanHAGandyDRBourkeE. Fenoprofen nephropathy: lipoid nephrosis and interstitial nephritis. Am J Med1982; 72: 81–7.
46.
BrezinJHKatzSMSchwartzABChinitzJL. Reversible renal failure and nephrotic syndrome associated with nonsteroidal antiinflammatory drugs. N Engl J Med1979; 301: 1271–3.
47.
CurtGAKaldanyAWhitleyLG. Reversible rapidly progressive renal failure with nephrotic syndrome due to fenoprofen calcium. Ann Intern Med1980; 92: 72–3.
48.
McCarthyJTSchwartzGLBlairTJPieridesAMVan Dan BergCJ. Reversible nonoliguric acute renal failure associated with zomepirac therapy. Mayo Clin Proc1982; 57: 351–4.
49.
BenderWLWheltonABeschornerWEDarwishMOHall-CraggsMSolezK. Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs. Am J Med1984; 76: 1006–12.
50.
TorresVE. Present and future of nonsteroidal anti-inflammatory drugs in nephrology (editorial). Mayo Clin Proc1982; 57: 389–93.
51.
NanraRSStuart-TaylorJDeleonAHWhiteKH. Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia. Kidney Int1978; 13: 79–92.
52.
Analgesic-associated kidney disease: concensus development statement. Report of the National Institutes of Health Consensus Development Conference on Analgesic-Associated Kidney Disease. Bethesda, MD: National Institutes of Health, 1984; 5 (2).
